These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3288621)

  • 1. The expression in Escherichia coli of recombinant human platelet factor 4, a protein with immunoregulatory activity.
    Barone AD; Ghrayeb J; Hammerling U; Zucker MB; Thorbecke GJ
    J Biol Chem; 1988 Jun; 263(18):8710-5. PubMed ID: 3288621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic and biochemic properties of recombinant platelet factor 4 demonstrate identity with the native protein.
    Park KS; Rifat S; Eck H; Adachi K; Surrey S; Poncz M
    Blood; 1990 Mar; 75(6):1290-5. PubMed ID: 2178704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a high-yield expression and purification system for platelet factor 4.
    Huynh A; Arnold DM; Moore JC; Smith JW; Kelton JG; Nazy I
    Platelets; 2018 May; 29(3):249-256. PubMed ID: 29172900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.
    Maione TE; Gray GS; Hunt AJ; Sharpe RJ
    Cancer Res; 1991 Apr; 51(8):2077-83. PubMed ID: 1706960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovine platelet factor 4: purification, amino acid sequence, radioimmunoassay and comparison with platelet factor 4 of other species.
    Shigeta O; Lu WQ; Holt JC; Edmunds LH; Niewiarowski S
    Thromb Res; 1991 Nov; 64(4):509-20. PubMed ID: 1788836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory activity of peptides related to platelet factor 4.
    Zucker MB; Katz IR; Thorbecke GJ; Milot DC; Holt J
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7571-4. PubMed ID: 2678107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of active recombinant platelet factor 4 from a cleavable fusion protein.
    Myers JA; Gray GS; Peters DJ; Grimaila RJ; Hunt AJ; Maione TE; Mueller WT
    Protein Expr Purif; 1991; 2(2-3):136-43. PubMed ID: 1821782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviation of immunosuppression in vitro by recombinant platelet factor 4.
    Katz IR; Thorbecke GJ; Zucker MB
    Int Immunol; 1992 Feb; 4(2):183-90. PubMed ID: 1535785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-yield production of recombinant platelet factor 4 by harnessing and honing the gram-negative bacterial secretory apparatus.
    Ataei S; Taheri MN; Tamaddon G; Behzad-Behbahani A; Taheri F; Rahimi A; Zare F; Amirian N
    PLoS One; 2020; 15(5):e0232661. PubMed ID: 32379796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycistronic expression of human platelet factor 4 with heparin-neutralizing activity in Escherichia coli.
    Duan Y; Wang Z; Wu W; Fang Z; Huang H
    Biosci Biotechnol Biochem; 2012; 76(10):1855-60. PubMed ID: 23047095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of novel monoclonal antibodies against rabbit platelet factor four.
    Cazzola F; Saggin L; Callegaro L
    Hybridoma; 1992 Feb; 11(1):61-9. PubMed ID: 1737641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High efficient expression of recombinant human platelet factor IV in Pichia pastoris].
    Wang C; Xie Y; Wang T; Yang W; Li C; Zhou J
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):138-40. PubMed ID: 11877065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
    Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
    Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human beta-thromboglobulin gene. Comparison with the gene for platelet factor 4.
    Majumdar S; Gonder D; Koutsis B; Poncz M
    J Biol Chem; 1991 Mar; 266(9):5785-9. PubMed ID: 1826003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.
    Amiral J; Pouplard C; Vissac AM; Walenga JM; Jeske W; Gruel Y
    Br J Haematol; 2000 May; 109(2):336-41. PubMed ID: 10848821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography.
    Medici I; Di Martino A; Cella G; Callegaro L; Prosdocimi M
    Thromb Res; 1989 May; 54(4):277-87. PubMed ID: 2763268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of recombinant single chain Fv antibody that recognizes platelet glycoprotein Ibalpha.
    Dai K; Zhu H; Ruan C
    Thromb Res; 2003 Jan; 109(2-3):137-44. PubMed ID: 12706643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
    Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
    Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
    Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
    Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.